glp-1 euglycemic dka diabetic ketoacidosis in the era of SGLT-2 inhibitors Recommendations for action in practice

we conducted this emulated target trial to evaluate the risk of developing incident PsA in T2DM patients treated with SGLT2i, GLP-1 RA, and DPP-4i.

Calculate your daily protein target on a GLP-1 from your goal weight, using the 1.2 to 1.6 g per kg range that protects muscle during weight loss.

People are losing 15, 20 percent of their body weight

But until our policies evolve to reflect the full value these therapies can deliver, we risk missing a major opportunity to improve lives and lower long-term costs

Demand for GLP-1 medications is booming, but healthy, sustained weight loss takes more than just medication

Learn why retatrutide causes diarrhea, what clinical trials reveal about GI side effects by dose, and proven strategies to manage digestive issues.